Organ-on-Chips Market Report and Forecast 2025-2034
Description
The global organ-on-chips market was valued at USD 136.52 Million in 2024, driven by increasing investment and funding for organ-on-chip technologies across the globe. The market is anticipated to grow at a CAGR of 35.28% during the forecast period of 2025-2034, with the values likely to reach USD 2802.41 Million by 2034.
Organ-on-chips Market Overview
Organ-on-chip products includes instrument systems, chips, consumables, and software designed for different organ types. These miniature tissues in microfluidic devices simulate human physiology, assisting in studies on disease mechanisms and treatments. Healthcare advancements and organ transplants are the main factors driving market growth. Other market trends include an influx of investments from governments and affluent healthcare companies as well as rising application of these chips across several healthcare domains, owing to its various benefits.
Organ-on-Chips Market Growth Drivers
Technology Advancement to Boost the Market Demand
The development of organ-on-chip technology is increasing as it offers personalized medicine options and as an alternative to animal testing. The market growth is driven by governments putting in investments to facilitate the development of technically advanced products. For instance, India's BioE3 policy promotes progress in precision therapeutics and biologics, fostering the development of organ-on-chip tech tailored to the specific needs of each patient.
Increasing Demand for Animal-Free Testing to Elevate the Organ-on-Chips Market Value
The increase in popularity of animal-free testing methods is fueling the growth of the market. The cutting-edge technology of organ-on-chip is transforming biomedical research and drug development by mimicking human organ functions in a lab setting. Its cost-effectiveness, ability to process large amounts of data quickly, and ethical attractiveness all contribute to its value in the healthcare and pharmaceutical sectors, thereby, fueling market growth.
Organ-on-Chips Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Rise in Organ Transplantation
The demand for organ-on-chip technology is increasing due to the growing demand for organ transplants. Lab-created organs and systems imitate human biology, providing answers to the lack of donor organs and enhancing drug testing and disease modeling in regenerative medicine.
Increasing Application Across Various Healthcare Domains to Boost Organ-On-Chips Market Demand
The increasing need for genetic and metabolic research, in vitro analysis, and real-time cell monitoring is leading to a rise in the incorporation of organ-on-chips in healthcare. Progress in biology, microfabrication, and microfluidics is improving the abilities for research and drug testing.
Rising Partnerships Among Market Players
Collaborations between companies are increasing in the market, thereby, enhancing drug development and personalized medicine. Pharmaceutical and biotech companies are collaborating to merge knowledge and broaden market coverage. This partnership aims to incorporate cutting-edge organ-on-chip technologies into drug testing, enhancing research capacity and promoting commercialization.
Growth in Investment and Funding
There is an increasing investment trend in the global organ-on-chips market, reflecting optimism in its ability to transform drug development and personalized medicine. Different organizations are investing resources in these platforms, speeding up research and development to improve technological capabilities.
Organ-on-Chips Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type:
Segmentation Based on Type to Witness Substantial Growth
The market segmentation by type is divided into products and services. Products are further categorized into liver-on-chip, lung-on-chip, kidney-on-chip, heart-on-chip among others. The product category is projected to lead as these chips are undergoing constant technical developments to improve the quality of outcomes.
Organ-on-Chips Market Analysis by Region
The market segmentation based on region is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is at the forefront because of the presence of a well-developed infrastructure, backing from the government, and the high incidence of various diseases. Europe is experiencing rapid growth due to diseases, advancements in technology, research, and development efforts by governments as well as key market players in the region.
Leading Players in the Organ-on-Chips Market
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis and strategic initiatives by the leading players. The major companies in the market are as follows:
Novartis AG
Novartis is a multinational healthcare company headquartered in Basel, Switzerland. The company has its focus on discovering, developing, manufacturing, and marketing prescription and generic pharmaceutical products, as well as eye care products. They provide treatment for various diseases.
Roche Holding AG
Roche is a Swiss company in the healthcare sector that has branches in pharmaceuticals and diagnostics. They are at the forefront of the worldwide organ-on-a-chip industry, employing cutting-edge technologies to replicate human organs and enhance drug development via early evaluations of effectiveness and toxicity.
Abbvie Inc.
AbbVie Inc., located in North Chicago, Illinois, progresses research on eye conditions within its eye care sector, adding to the organ-on-a-chip market value. Their emphasis on creative therapies is in line with this technology, improving patient care in the field of ophthalmology.
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG, a part of Carl Zeiss AG, manufactures equipment for eye examinations, medical lasers, and products for different medical sectors. ZEISS Ventures supports organ-on-chip startups by investing in them to improve sensors and data solutions for in-vitro diagnostics and personalized medicine, ultimately boosting market growth and innovation.
Other key players in the market include Johnson & Johnson, Bausch Health Companies Inc., Santen Pharmaceutical Co., Ltd., HOYA Corporation, and Glaukos Corporation.
Key Questions Answered in the Organ-on-Chips Market Report
Organ-on-chips Market Overview
Organ-on-chip products includes instrument systems, chips, consumables, and software designed for different organ types. These miniature tissues in microfluidic devices simulate human physiology, assisting in studies on disease mechanisms and treatments. Healthcare advancements and organ transplants are the main factors driving market growth. Other market trends include an influx of investments from governments and affluent healthcare companies as well as rising application of these chips across several healthcare domains, owing to its various benefits.
Organ-on-Chips Market Growth Drivers
Technology Advancement to Boost the Market Demand
The development of organ-on-chip technology is increasing as it offers personalized medicine options and as an alternative to animal testing. The market growth is driven by governments putting in investments to facilitate the development of technically advanced products. For instance, India's BioE3 policy promotes progress in precision therapeutics and biologics, fostering the development of organ-on-chip tech tailored to the specific needs of each patient.
Increasing Demand for Animal-Free Testing to Elevate the Organ-on-Chips Market Value
The increase in popularity of animal-free testing methods is fueling the growth of the market. The cutting-edge technology of organ-on-chip is transforming biomedical research and drug development by mimicking human organ functions in a lab setting. Its cost-effectiveness, ability to process large amounts of data quickly, and ethical attractiveness all contribute to its value in the healthcare and pharmaceutical sectors, thereby, fueling market growth.
Organ-on-Chips Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Rise in Organ Transplantation
The demand for organ-on-chip technology is increasing due to the growing demand for organ transplants. Lab-created organs and systems imitate human biology, providing answers to the lack of donor organs and enhancing drug testing and disease modeling in regenerative medicine.
Increasing Application Across Various Healthcare Domains to Boost Organ-On-Chips Market Demand
The increasing need for genetic and metabolic research, in vitro analysis, and real-time cell monitoring is leading to a rise in the incorporation of organ-on-chips in healthcare. Progress in biology, microfabrication, and microfluidics is improving the abilities for research and drug testing.
Rising Partnerships Among Market Players
Collaborations between companies are increasing in the market, thereby, enhancing drug development and personalized medicine. Pharmaceutical and biotech companies are collaborating to merge knowledge and broaden market coverage. This partnership aims to incorporate cutting-edge organ-on-chip technologies into drug testing, enhancing research capacity and promoting commercialization.
Growth in Investment and Funding
There is an increasing investment trend in the global organ-on-chips market, reflecting optimism in its ability to transform drug development and personalized medicine. Different organizations are investing resources in these platforms, speeding up research and development to improve technological capabilities.
Organ-on-Chips Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type:
- Product
- Liver-on-chip
- Lung-on-chip
- Kidney-on-chip
- Heart-on-chip
- Others
- Service
- Polydimethylsiloxane (PDMS)
- Polymer
- Glass
- Single-organ model
- Multi-organ model
- Drug Discovery
- Toxicity Testing
- Disease Modeling
- Personalized Medicine
- Others
- Pharmaceutical and Biotechnological Companies
- Academic and Research Institutes
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Segmentation Based on Type to Witness Substantial Growth
The market segmentation by type is divided into products and services. Products are further categorized into liver-on-chip, lung-on-chip, kidney-on-chip, heart-on-chip among others. The product category is projected to lead as these chips are undergoing constant technical developments to improve the quality of outcomes.
Organ-on-Chips Market Analysis by Region
The market segmentation based on region is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is at the forefront because of the presence of a well-developed infrastructure, backing from the government, and the high incidence of various diseases. Europe is experiencing rapid growth due to diseases, advancements in technology, research, and development efforts by governments as well as key market players in the region.
Leading Players in the Organ-on-Chips Market
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis and strategic initiatives by the leading players. The major companies in the market are as follows:
Novartis AG
Novartis is a multinational healthcare company headquartered in Basel, Switzerland. The company has its focus on discovering, developing, manufacturing, and marketing prescription and generic pharmaceutical products, as well as eye care products. They provide treatment for various diseases.
Roche Holding AG
Roche is a Swiss company in the healthcare sector that has branches in pharmaceuticals and diagnostics. They are at the forefront of the worldwide organ-on-a-chip industry, employing cutting-edge technologies to replicate human organs and enhance drug development via early evaluations of effectiveness and toxicity.
Abbvie Inc.
AbbVie Inc., located in North Chicago, Illinois, progresses research on eye conditions within its eye care sector, adding to the organ-on-a-chip market value. Their emphasis on creative therapies is in line with this technology, improving patient care in the field of ophthalmology.
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG, a part of Carl Zeiss AG, manufactures equipment for eye examinations, medical lasers, and products for different medical sectors. ZEISS Ventures supports organ-on-chip startups by investing in them to improve sensors and data solutions for in-vitro diagnostics and personalized medicine, ultimately boosting market growth and innovation.
Other key players in the market include Johnson & Johnson, Bausch Health Companies Inc., Santen Pharmaceutical Co., Ltd., HOYA Corporation, and Glaukos Corporation.
Key Questions Answered in the Organ-on-Chips Market Report
- What was the organ-on-chips market value in 2024?
- What is the organ-on-chips market forecast outlook for 2025-2034?
- What are the regional markets covered in the EMR report?
- What is the market segmentation based on the type?
- What is the market segmentation based on the material?
- What is the market breakup based on the model type?
- What is the market breakup based on the application?
- What is the market breakup based on the end user?
- What major factors aiding the organ-on-chips market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the major drivers, opportunities, and restraints in the market?
- What are the major trends influencing the market?
- Which regional market is expected to dominate the market share in the forecast period?
- Which country is likely to experience elevated growth during the forecast period?
- Who are the key players involved in the organ-on-chips market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Table of Contents
400 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Organ-on-Chips Market Overview
- 3.1 Global Organ-on-Chips Market Historical Value 2018-2024
- 3.2 Global Organ-on-Chips Market Forecast Value 2025-2034
- 4 Vendor Positioning Analysis
- 4.1 Key Vendors
- 4.2 Prospective Leaders
- 4.3 Niche Leaders
- 4.4 Disruptors
- 5 Global Organ-on-Chips Market Landscape*
- 5.1 Global Organ-on-Chips Market: Developers Landscape
- 5.1.1 Analysis by Year of Establishment
- 5.1.2 Analysis by Company Size
- 5.1.3 Analysis by Region
- 5.2 Global Organ-on-Chips Market: Product Landscape
- 5.2.1 Analysis by Product
- 6 Global Organ-on-Chips Market Dynamics
- 6.1 Market Drivers and Constraints
- 6.2 SWOT Analysis
- 6.2.1 Strengths
- 6.2.2 Weaknesses
- 6.2.3 Opportunities
- 6.2.4 Threats
- 6.3 PESTEL Analysis
- 6.3.1 Political
- 6.3.2 Economic
- 6.3.3 Social
- 6.3.4 Technological
- 6.3.5 Legal
- 6.3.6 Environment
- 6.4 Porter’s Five Forces Model
- 6.4.1 Bargaining Power of Suppliers
- 6.4.2 Bargaining Power of Buyers
- 6.4.3 Threat of New Entrants
- 6.4.4 Threat of Substitutes
- 6.4.5 Degree of Rivalry
- 6.5 Key Demand Indicators
- 6.6 Key Price Indicators
- 6.7 Industry Events, Initiatives, and Trends
- 6.8 Value Chain Analysis
- 7 Global Organ-on-Chips Market Segmentation 218-2034
- 7.1 Global Organ-on-Chips Market 2018-2034 by Type
- 7.1.1 Market Overview
- 7.1.2 Product
- 7.1.2.1 Liver-on-chip
- 7.1.2.2 Lung-on-chip
- 7.1.2.3 Kidney-on-chip
- 7.1.2.4 Heart-on-chip
- 7.1.2.5 Others
- 7.1.3 Service
- 7.2 Global Organ-on-Chips Market 2018-2034 by Material
- 7.2.1 Market Overview
- 7.2.2 Polydimethylsiloxane (PDMS)
- 7.2.3 Polymer
- 7.2.4 Glass
- 7.3 Global Organ-on-Chips Market 2018-2034 by Model Type
- 7.3.1 Market Overview
- 7.3.2 Single-organ model
- 7.3.3 Multi-organ model
- 7.4 Global Organ-on-Chips Market 2018-2034 by Application
- 7.4.1 Market Overview
- 7.4.2 Drug Discovery
- 7.4.3 Toxicity Testing
- 7.4.4 Disease Modeling
- 7.4.5 Personalized Medicine
- 7.4.6 Others
- 7.5 Global Organ-on-Chips Market 2018-2034 by End User
- 7.5.1 Market Overview
- 7.5.2 Pharmaceutical and Biotechnological Companies
- 7.5.3 Academic and Research Institutes
- 7.5.4 Others
- 7.6 Global Organ-on-Chips Market 2018-2034 by Region
- 7.6.1 Market Overview
- 7.6.2 North America
- 7.6.3 Europe
- 7.6.4 Asia Pacific
- 7.6.5 Latin America
- 7.6.6 Middle East and Africa
- 8 North America Organ-on-Chips Market 218-2034
- 8.1 North America Organ-on-Chips Market 2018-2034 by Type
- 8.1.1 Market Overview
- 8.1.2 Product
- 8.1.2.1 Liver-on-chip
- 8.1.2.2 Lung-on-chip
- 8.1.2.3 Kidney-on-chip
- 8.1.2.4 Heart-on-chip
- 8.1.2.5 Others
- 8.1.3 Service
- 8.2 North America Organ-on-Chips Market 2018-2034 by Material
- 8.2.1 Market Overview
- 8.2.2 Polydimethylsiloxane (PDMS)
- 8.2.3 Polymer
- 8.2.4 Glass
- 8.3 North America Organ-on-Chips Market 2018-2034 by Model Type
- 8.3.1 Market Overview
- 8.3.2 Single-organ model
- 8.3.3 Multi-organ model
- 8.4 North America Organ-on-Chips Market 2018-2034 by Application
- 8.4.1 Market Overview
- 8.4.2 Drug Discovery
- 8.4.3 Toxicity Testing
- 8.4.4 Disease Modeling
- 8.4.5 Personalized Medicine
- 8.4.6 Others
- 8.5 North America Organ-on-Chips Market 2018-2034 by End User
- 8.5.1 Market Overview
- 8.5.2 Pharmaceutical and Biotechnological Companies
- 8.5.3 Academic and Research Institutes
- 8.5.4 Others
- 8.6 North America Organ-on-Chips Market 2018-2034 by Country
- 8.6.1 United States of America
- 8.6.2 Canada
- 9 Europe Organ-on-Chips Market 218-2034
- 9.1 Europe Organ-on-Chips Market 2018-2034 by Type
- 9.1.1 Market Overview
- 9.1.2 Product
- 9.1.2.1 Liver-on-chip
- 9.1.2.2 Lung-on-chip
- 9.1.2.3 Kidney-on-chip
- 9.1.2.4 Heart-on-chip
- 9.1.2.5 Others
- 9.1.3 Service
- 9.2 Europe Organ-on-Chips Market 2018-2034 by Material
- 9.2.1 Market Overview
- 9.2.2 Polydimethylsiloxane (PDMS)
- 9.2.3 Polymer
- 9.2.4 Glass
- 9.3 Europe Organ-on-Chips Market 2018-2034 by Model Type
- 9.3.1 Market Overview
- 9.3.2 Single-organ model
- 9.3.3 Multi-organ model
- 9.4 Europe Organ-on-Chips Market 2018-2034 by Application
- 9.4.1 Market Overview
- 9.4.2 Drug Discovery
- 9.4.3 Toxicity Testing
- 9.4.4 Disease Modeling
- 9.4.5 Personalized Medicine
- 9.4.6 Others
- 9.5 Europe Organ-on-Chips Market 2018-2034 by End User
- 9.5.1 Market Overview
- 9.5.2 Pharmaceutical and Biotechnological Companies
- 9.5.3 Academic and Research Institutes
- 9.5.4 Others
- 9.6 Europe Organ-on-Chips Market 2018-2034 by Country
- 9.6.1 United Kingdom
- 9.6.2 Germany
- 9.6.3 France
- 9.6.4 Italy
- 9.6.5 Others
- 10 Asia Pacific Organ-on-Chips Market 218-2034
- 10.1 Asia Pacific Organ-on-Chips Market 2018-2034 by Type
- 10.1.1 Market Overview
- 10.1.2 Product
- 10.1.2.1 Liver-on-chip
- 10.1.2.2 Lung-on-chip
- 10.1.2.3 Kidney-on-chip
- 10.1.2.4 Heart-on-chip
- 10.1.2.5 Others
- 10.1.3 Service
- 10.2 Asia Pacific Organ-on-Chips Market 2018-2034 by Material
- 10.2.1 Market Overview
- 10.2.2 Polydimethylsiloxane (PDMS)
- 10.2.3 Polymer
- 10.2.4 Glass
- 10.3 Asia Pacific Organ-on-Chips Market 2018-2034 by Model Type
- 10.3.1 Market Overview
- 10.3.2 Single-organ model
- 10.3.3 Multi-organ model
- 10.4 Asia Pacific Organ-on-Chips Market 2018-2034 by Application
- 10.4.1 Market Overview
- 10.4.2 Drug Discovery
- 10.4.3 Toxicity Testing
- 10.4.4 Disease Modeling
- 10.4.5 Personalized Medicine
- 10.4.6 Others
- 10.5 Asia Pacific Organ-on-Chips Market 2018-2034 by End User
- 10.5.1 Market Overview
- 10.5.2 Pharmaceutical and Biotechnological Companies
- 10.5.3 Academic and Research Institutes
- 10.5.4 Others
- 10.6 Asia Pacific Organ-on-Chips Market 2018-2034 by Country
- 10.6.1 China
- 10.6.2 Japan
- 10.6.3 India
- 10.6.4 ASEAN
- 10.6.5 Australia
- 10.6.6 Others
- 11 Latin America Organ-on-Chips Market 218-2034
- 11.1 Latin America Organ-on-Chips Market 2018-2034 by Type
- 11.1.1 Market Overview
- 11.1.2 Product
- 11.1.2.1 Liver-on-chip
- 11.1.2.2 Lung-on-chip
- 11.1.2.3 Kidney-on-chip
- 11.1.2.4 Heart-on-chip
- 11.1.2.5 Others
- 11.1.3 Service
- 11.2 Latin America Organ-on-Chips Market 2018-2034 by Material
- 11.2.1 Market Overview
- 11.2.2 Polydimethylsiloxane (PDMS)
- 11.2.3 Polymer
- 11.2.4 Glass
- 11.3 Latin America Organ-on-Chips Market 2018-2034 by Model Type
- 11.3.1 Market Overview
- 11.3.2 Single-organ model
- 11.3.3 Multi-organ model
- 11.4 Latin America Organ-on-Chips Market 2018-2034 by Application
- 11.4.1 Market Overview
- 11.4.2 Drug Discovery
- 11.4.3 Toxicity Testing
- 11.4.4 Disease Modeling
- 11.4.5 Personalized Medicine
- 11.4.6 Others
- 11.5 Latin America Organ-on-Chips Market 2018-2034 by End User
- 11.5.1 Market Overview
- 11.5.2 Pharmaceutical and Biotechnological Companies
- 11.5.3 Academic and Research Institutes
- 11.5.4 Others
- 11.6 Latin America Organ-on-Chips Market 2018-2034 by Country
- 11.6.1 Brazil
- 11.6.2 Argentina
- 11.6.3 Mexico
- 11.6.4 Others
- 12 Middle East and Africa Organ-on-Chips Market 218-2034
- 12.1 Middle East and Africa Organ-on-Chips Market 2018-2034 by Type
- 12.1.1 Market Overview
- 12.1.2 Product
- 12.1.2.1 Liver-on-chip
- 12.1.2.2 Lung-on-chip
- 12.1.2.3 Kidney-on-chip
- 12.1.2.4 Heart-on-chip
- 12.1.2.5 Others
- 12.1.3 Service
- 12.2 Middle East and Africa Organ-on-Chips Market 2018-2034 by Material
- 12.2.1 Market Overview
- 12.2.2 Polydimethylsiloxane (PDMS)
- 12.2.3 Polymer
- 12.2.4 Glass
- 12.3 Middle East and Africa Organ-on-Chips Market 2018-2034 by Model Type
- 12.3.1 Market Overview
- 12.3.2 Single-organ model
- 12.3.3 Multi-organ model
- 12.4 Middle East and Africa Organ-on-Chips Market 2018-2034 by Application
- 12.4.1 Market Overview
- 12.4.2 Drug Discovery
- 12.4.3 Toxicity Testing
- 12.4.4 Disease Modeling
- 12.4.5 Personalized Medicine
- 12.4.6 Others
- 12.5 Middle East and Africa Organ-on-Chips Market 2018-2034 by End User
- 12.5.1 Market Overview
- 12.5.2 Pharmaceutical and Biotechnological Companies
- 12.5.3 Academic and Research Institutes
- 12.5.4 Others
- 12.6 Middle East and Africa Organ-on-Chips Market 2018-2034 by Country
- 12.6.1 Saudi Arabia
- 12.6.2 United Arab Emirates
- 12.6.3 Nigeria
- 12.6.4 South Africa
- 12.6.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication Year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 14 Grants Analysis
- 14.1 Analysis by Year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Application
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by NIH Departments
- 14.7 Analysis by Recipient Organization
- 15 Funding and Investment Analysis
- 15.1 Analysis by Funding Instances
- 15.2 Analysis by Drug Class of Funding
- 15.3 Analysis by Funding Amount
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Leading Investors
- 15.6 Analysis by Geography
- 16 Strategic Initiatives
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Drug Class of Partnership
- 16.3 Analysis by Leading Players
- 16.4 Analysis by Geography
- 17 Supplier Landscape
- 17.1 Market Share Analysis, By Region (Top 5 Companies)
- 17.1.1 Market Share Analysis: Global
- 17.1.2 Market Share Analysis: North America
- 17.1.3 Market Share Analysis: Europe
- 17.1.4 Market Share Analysis: Asia Pacific
- 17.1.5 Market Share Analysis: Others
- 17.2 Novartis AG
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Company News and Development
- 17.2.5 Certifications
- 17.3 Johnson & Johnson
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Company News and Development
- 17.3.5 Certifications
- 17.4 Bausch Health Companies Inc.
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Company News and Development
- 17.4.5 Certifications
- 17.5 Roche Holding AG
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Company News and Development
- 17.5.5 Certifications
- 17.6 Abbvie Inc.
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Company News and Development
- 17.6.5 Certifications
- 17.7 Carl Zeiss Meditec AG
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Company News and Development
- 17.7.5 Certifications
- 17.8 Santen Pharmaceutical Co., Ltd.
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Company News and Development
- 17.8.5 Certifications
- 17.9 HOYA Corporation
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Company News and Development
- 17.9.5 Certifications
- 17.10 Glaukos Corporation
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Company News and Development
- 17.10.5 Certifications
- 18 Global Organ-on-Chips Market – Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
